Scinovex
article Open AccessTop 1% cited

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

BMC Cancer · 2016 · Vol. 16(1) · pp. 503–503
Jens HoeppnerFlorian LordickThomas BrunnerTorben GlatzPeter BronsertNadine RöthlingClaudia SchmoorDietmar LorenzChristian EllUlrich T. HoptJ. R. Siewert

Abstract

NCT02509286 (July 22, 2015).

Esophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesMetastasis and carcinoma case studiesMedicineSurgical oncologyPerioperativeEsophageal adenocarcinomaProtocol (science)Randomized controlled trialOncologyChemotherapyAdenocarcinomaInternal medicine

MeSH terms

AdenocarcinomaAdultAgedAntineoplastic Combined Chemotherapy ProtocolsDrug TherapyEsophageal NeoplasmsEsophagusFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalProspective StudiesQuality of LifeRadiotherapy

Funding

  • Deutsche Forschungsgemeinschaft
  • Army Research Office
Citations
344
FWCI
21.03
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.